The NHS reports a record high number of ADHD medication prescriptions, with new figures showing a sharp increase in the number of adults receiving treatment. One report says the number of adults on ADHD pills rises by about 41,000 over a three-month period, and that the total has doubled over roughly two years.
The outlets also note debate around the safety of these medicines, citing claims that the tablets are linked to serious adverse effects. However, the articles provided here rely on similar figures and do not detail which specific medicines are involved, the scale of any side-effect outcomes, or how causation is established versus reported associations.
Overall, the coverage is centered on the growth in prescribing levels and the resulting attention to risks and monitoring, using NHS prescription data as the main evidence for the increase. Differences, where present, are primarily in the emphasis placed on the “record” nature of the prescribing rise and the mention of potential severe side effects.
